Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma.
Song S, Chen Q, Li Y, Lei G, Scott A, Huo L, Li CY, Estrella JS, Correa A, Pizzi MP, Ma L, Jin J, Liu B, Wang Y, Xiao L, Hofstetter WL, Lee JH, Weston B, Bhutani M, Shanbhag N, Johnson RL, Gan B, Wei S, Ajani JA.
Song S, et al. Among authors: estrella js.
Gut. 2021 Dec;70(12):2238-2248. doi: 10.1136/gutjnl-2020-321175. Epub 2021 Jan 24.
Gut. 2021.
PMID: 33487592
Free PMC article.
Clinical Trial.